Dr. Ziaeian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 UCLA Medical Plz
Ste 630
Los Angeles, CA 90024Phone+1 310-825-9011Fax+1 310-825-2092
Education & Training
- Ronald Reagan UCLA Medical CenterPost-Doctoral Fellowship, 2013 - 2016
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 2012 - 2016
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2008 - 2011
- University of California, Irvine, School of MedicineClass of 2008
Certifications & Licensure
- CA State Medical License 2011 - 2025
- CT State Medical License 2011 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- National Board of EchocardiographyDiplomate
Publications & Presentations
PubMed
- 9 citationsReadmission and resource utilization after orthotopic heart transplant versus ventricular assist device in the National Readmissions Database, 2010-2014.Laith Mukdad, Aditya Mantha, Esteban Aguayo, Yas Sanaiha, Yen-Yi Juo
Surgery. 2018-08-01 - 254 citations2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Cli...Donna K Arnett, Roger S Blumenthal, Michelle A Albert, Andrew B Buroker, Zachary D Goldberger
Circulation. 2019-09-10 - 2084 citations2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular DiseaseDonna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, Erin D. Michos, Andrew B. Buroker
Journal of the American College of Cardiology. 2019-03-17
Journal Articles
- National Trends in Heart Failure Hospitalizations and Readmissions from 2010 to 2017Manyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian, JAMA Cardiology
- Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy with Outcome for Patients with Heart FailureBoback Ziaeian, Clyde W Yancy, JAMA Cardiology
- Perceived Barriers to Sacubitril/Valsartan Use in Patients with Heart FailureKevin S Shah, Boback Ziaeian, Freny V Mody, Ali Nsair, Gregg C Fonarow, Journal of Cardiac Failure
- Join now to see all
Authored Content
- Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy with Outcome for Patients with Heart FailureMay 2020
- Perceived Barriers to Sacubitril/Valsartan Use in Patients with Heart FailureAugust 2018
Press Mentions
- More Americans Hospitalized, Readmitted for Heart FailureFebruary 16th, 2021
- Surgisphere Data Used in Two COVID Studies Called into QuestionJune 3rd, 2020
- Arterial Thrombosis in Patients with CancerApril 7th, 2020
- Join now to see all
Other Languages
- Spanish, Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: